Reference
1. European Heart Network, "Cardiovascular Disease Statistics" (2011).
http://www.ehnheart.org/, accessed 6 Oct. 2011.
2. European Heart Network, "Children and Obesity and Associated Avoidable Chronic Diseases" (2011),
http://www.ehnheart.org/, accessed 6 Oct. 2011.
3. World Heart Federation, "World Heart Day" (2011),
http://www.world-heart-federation.org/, accessed 6 Oct. 2011.
4. L. Nainggolan, "FDA Alert: Dronedarone and severe liver injury", http://theheart.org/ (2011),
http://www.theheart.org/, accessed 6 Oct. 2011.
5. European Heart Network
http://www.ehnheart.org/, accessed 6 Oct. 2011.
6. URCH Publishing, Pharmaceutical Market Trends, 2010–2014 (UK, 2010).
7. EFPIA, "Enlightened self-interest delivering wider insights?", blog post, (2010), http://efpia.blogspot.com/, accessed 6 Oct. 2011.
8. Gonzalo Calvo, "Cardiovascular Biomarkers: A Regulatory Perspective", Presentation from the EMEA/EFPIA Workshop On Biomarkers
(2009).
|
